PillsPharmac
  • Home
Successful Search?
Try one of the below options to narrow down your search.
Google Custom Search:
Loading
PHARMAC Search:

Documents may be browsed by date, eg; Today, May, 2013.

Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...

Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013

Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.

Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.

Remember to group or statements with parentheses if they are beside and statements.

Search examples

consultation
Search for consultations
media and not antibiotics
Search for media related documents that don't mention antibiotics.
(media or consultation) and vaccines
Search for media releases and consultation documents mentioning vaccinations.

Search term: archive

2012 / 01

Your search is limited to one month, search the whole site for archive.

PHARMAC documents that matched your search:

Prev, Next – Page 1 of 1 (3 documents)

icon

Proposal to fund lapatinib and pazopanib and amend funding criteria for trastuzumab; Closing Date: Closed; Contact: Jackie Evans (7 pages, 154 KB)
2012/01/26
archive, consultation

26 January 2012 Proposal to fund lapatinib and pazopanib and amend funding criteria for trastuzumab PHARMAC is seeking feedback on a proposal to:  Fund lapatinib (Tykerb) as an alternative to trastuzumab (Herceptin) for the first line treatment of patients…

text


icon

Widen access to ursodeoxycholic acid; Closing Date: Closed; Contact: Natalie Davis (2 pages, 126 KB)
2012/01/20
archive, consultation

20 January 2012 Proposal to widen access to ursodeoxycholic acid PHARMAC is seeking feedback on a proposal to widen funded access to ursodeoxycholic acid for prevention of veno-occlusive disease in patients receiving high dose conditioning therapy prior to bone marrow…

text


icon

Proposal to fully fund Symbicort Turbuhaler and Vannair; Closing Date: Closed; Contact: Christine Chapman (3 pages, 127 KB)
2012/01/17
archive, consultation

17 January 2012 Proposal to fully fund Symbicort Turbuhaler and Vannair PHARMAC is seeking feedback on a proposal to fully subsidise budesonide with eformoterol (Symbicort Turbuhaler and Vannair) from 1 March 2012 through a provisional agreement with AstraZeneca. In summary,…

text


Prev, Next – Page 1 of 1 (3 documents)

New Zealand GovernmentAbout Us | Contact Us